In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bromhexin Berlin Chemie Drug Master File in Korea (Bromhexin Berlin Chemie KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bromhexin Berlin Chemie. The MFDS reviews the Bromhexin Berlin Chemie KDMF as part of the drug registration process and uses the information provided in the Bromhexin Berlin Chemie KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bromhexin Berlin Chemie KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bromhexin Berlin Chemie API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bromhexin Berlin Chemie suppliers with KDMF on PharmaCompass.